This event has an open poster session. Posters can be submitted on any subject related to pregnancy
The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at
Program Outline
How can biomarkers be used to improve the management of pre-eclampsia
Professor Andrew Shennan, Kings College London, UK
Preeclampsia Human Placental Model
Professor Nandakumaran Moorkath, Faculty of Medicine, University of Kuwait
Stress, immune system functioning and perinatal depression: the impact of heightened systemic inflammation and risk of CVD later in life. Is pre-eclampsia the right model
Professor Meir Steiner, Professor Emeritus, McMaster University, Ontario, Canada
Placental Syncytiotrophoblast Vesicles In Normal Pregnancy And Pre-Eclampsia
Dr Dionne Tannetta, Senior Research Scientist, University of Oxford, UK
Central aortic pulse wave analysis parameters – a novel marker in prediction of hypertensive complications in pregnancy
Dr Ludwina Szczepaniak-Chicheł, MD, PhD, adiunct, Dept. of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, PolandPreeclampsia and the immune system: a close relationship
Dr Estibalitz Laresgoiti, Associate Professor, Attending Physician, American British Cowdray Medical Center, Mexico, National Institute of Perinatology; Mexico, School of Medicine, Monterrey Institute of Technology and Higher Education, Mexico
Role of metabolic Syndrome factors in pre-eclampsia
Dr Shipra Sonkusare, Dept. of Obstetrics + Gynaecology, Manipal University, India
Podocyturia as a diagnostic and prognostic marker of preeclampsia
Dr Vesna D. Garovic, Professor of Internal Medicine, Division of Nephology+Hypertension+Dept of Obstetrics+Gynaecology, Mayo Clinic, USA
Vitamin D3 deficiency/treatment during pregnancy and complications including preeclampsia
Dr Stella Nowicki, Professor Microbiology and Immunology, Meharry Medical College, Nashville, TN, USA
The hemostatic changes in preeclampsia, is there a place for anticoagulation treatment for the prevention of this syndrome
Professor Offer Erez, Director of Risk Management and Patients Safty Unit, Acting Director Maternal Fetal Medicine Unit, Soroka University Medical Center, Ben Gurion University of the Negev, Israel
Anesthetic Goals of Labor Analgesia in Preeclampsia
Dr Ayten Saracoglu, Assist. Prof. M.D., Department of Anesthesiology and Reanimation, Istanbul Bilim University Medical School, Turkey
Pre-eclampsia casts a long shadow
Professor Fiona Broughton Pipkin, Professor Emeritus of Perinatal Physiology, University of Nottingham Medical School, UK
Regional versus General Anesthesia for C/S in Severe Preeclampsia
Dr Kemal Tolga Saracoglu, Assistant Professor of Anesthesiology and Reanimation, Marmara University School of Medicine Istanbul Turkey
Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment
Dr Sarosh Rana, MD, Assistant Professor, Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA, USA
Pregnancy complicated by cervical cancer
Dr Wojciech Kolawa, Senior lecturer, University Hospital, Department of Gynecology and Oncology, Jagiellonian University, Krakow, Poland
Fetal haemodyanic assessment by magnetic resonance imaging
Dr Mike Seed, Pediatric Cardiologist and Radiologist, SickKids, Toronto, Canada
Was the Mona Lisa’s Smile the Result of a Pregnancy-associated Condition
Dr William Maloney, DDS, Clinical Associate Professor, New York University, USA
Information about prenatal examinations – A challenge in antenatal care
Associate Professor Susanne Georgsson Öhman, Senior Lecturer, Karolinska Institutet Department of women’s and children’s health, Stockholm, Sweden
The role of nutrition and genetics during pregnancy
Dr Anne Parle-McDermott, Lecturer in Genetics, Dublin City University, Ireland
Catheter Ablation of Arrhythmia in Pregnant Women
Dr John Ferguson, Associate Professor, University of Virginia Medical Center, USA
Additional Talks Include:
Mr Joost Schuitemaker, Managing Director, IQ Products, The Netherlands
Ms Ann Marie Barnard, Chief Executive Officer, Action on Pre-eclampsia
Dr Heather A. Boyd, Department of Epidemiology Research, Statens Serum Institut, Denmark
